ERBB2 and breast cancer: To provide a comprehensive model for evaluating potential drugs for treating PIK3CA/PTEN–wild‐type, HER2‐positive, trastuzumab‐resistant breast cancer, we established xenograft tumors in zebrafish and immunodeficient mice.